Medclair AB (NGM:MCLR) YoY EBITDA Growth : -162.86% (As of Sep. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Medclair AB YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Medclair AB's YoY EBITDA Growth for the quarter that ended in Sep. 2024 was -162.86%.

Medclair AB's EBITDA per Share for the three months ended in Sep. 2024 was kr-0.02.

Medclair AB YoY EBITDA Growth Historical Data

The historical data trend for Medclair AB's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medclair AB YoY EBITDA Growth Chart

Medclair AB Annual Data

Trend

Apr15

Apr16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

YoY EBITDA Growth

Get a 7-Day Free Trial

82.58

70.37

-1,087.50

106.32

466.67

Medclair AB Quarterly Data
	Dec18	Jun19	Dec19	Jun20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
YoY EBITDA Growth	Get a 7-Day Free Trial															202.94	-106.67	-42.31	92.86	-162.86

Medclair AB YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Medclair AB's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (A: Dec. 2023 )
=	(EBITDA per Share (A: Dec. 2023 )	-	EBITDA per Share (A: Dec. 2022 ))	/	\| EBITDA per Share (A: Dec. 2022 ) \|
=	(0.034	-	0.006)	/	\| 0.006 \|
=	466.67 %

Medclair AB's YoY EBITDA Growth for the quarter that ended in Sep. 2024 is calculated as:

	YoY EBITDA Growth (Q: Sep. 2024 )
=	(EBITDA per Share (Q: Sep. 2024 )	-	EBITDA per Share (Q: Sep. 2023 ))	/	\| EBITDA per Share (Q: Sep. 2023 )) \|
=	(-0.022	-	0.035)	/	\| 0.035 \|
=	-162.86 %

Medclair AB YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Medclair AB's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Medclair AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medclair AB (NGM:MCLR) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

Box 3113, Stockholm, SWE, 103 62

Website

https://www.medclair.com

Medclair AB operates in healthcare industry. The company has two units: Central Destruction Unit (CDU) and Mobile Destruction Unit (MDU) decomposes up to 99% of the nitrous oxide entering the unit, transforming it to nitrogen (N2) och oxygen (O2). It also provide solutions for various N2O methods such as double mask, single mask, mouthpiece, or free flow, which ensures a safe work environment for healthcare professionals.

Medclair AB Headlines

No Headlines